Same Indication

Ipilimumab vs Tramadol

Ipilimumab vs Tramadol: Overview

This comparison examines the pharmacological differences between Ipilimumab and Tramadol.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Tramadol: Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Tramadol — 5-7 hours.

Chemical Properties

Molecular Formula: Tramadol — C16H25NO2.

Molecular Weight: Tramadol — 263.3750 g/mol.

Type: Ipilimumab — Antibody; Tramadol — Small molecule.